SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-21-018767
Filing Date
2021-04-14
Accepted
2021-04-14 08:22:34
Documents
7
Period of Report
2021-05-26

Document Format Files

Seq Description Document Type Size
1 DEF 14A lyra-def14a_20210526.htm DEF 14A 795012
2 GRAPHIC gctuxiosuhss000001.jpg GRAPHIC 5033
3 GRAPHIC gctuxiosuhss000004.jpg GRAPHIC 892
4 GRAPHIC gctuxiosuhss000005.jpg GRAPHIC 47392
5 GRAPHIC gctuxiosuhss000003.jpg GRAPHIC 892
6 GRAPHIC gctuxiosuhss000006.jpg GRAPHIC 55311
7 GRAPHIC gctuxiosuhss000002.jpg GRAPHIC 5033
  Complete submission text file 0001564590-21-018767.txt   954942
Mailing Address 480 ARSENAL STREET WATERTOWN MA 02472
Business Address 480 ARSENAL STREET WATERTOWN MA 02472 617-373-4600
Lyra Therapeutics, Inc. (Filer) CIK: 0001327273 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39273 | Film No.: 21824576
SIC: 3841 Surgical & Medical Instruments & Apparatus